A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms

Infectious Diseases and Therapy · Published 2026-08-03 · DOI 10.1007/s40121-026-01419-z

Free full text

Authors (24)

Gunjan Kumar, Ravi Kant, Deepa Joshi, Kavita Singh, Jerin Jose Cherian, Kattula Rao Vinay Rajan, Shikha Malik, Saibal Das, Sudipto Pallab Roy, Vijay Satam, Rishi Tuhin Guria, Dewesh Kumar, Lakhan Majhee, Anjani Kumar, Manjunath Nookala Krishnamurthy, Lokesh Kumar Sharma, Akshata Chaudhary, Ivan Scandale, Sabine Specht, Samir Sahu, Meghanad Meher, Satyasundar Gajendra Mohapatra, Aparna Mukherjee, Taruna Madan Gupta

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kumar, G., Kant, R., Joshi, D., et al. (2026). A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms. Infectious Diseases and Therapy. https://doi.org/10.1007/s40121-026-01419-z

Related articles

• Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity · Infectious Diseases and Therapy · 2026 · Same journal
• Use of Isavuconazole in the Treatment of Cryptococcosis: A Real-World Case Series · Infectious Diseases and Therapy · 2026 · Same journal
• Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C · Infectious Diseases and Therapy · 2026 · Same journal
• Multicenter Real-World Outpatient Use of Intravenous Omadacycline · Infectious Diseases and Therapy · 2026 · Same journal
• Early Warning and Behavioural Intervention on the Cardiovascular Disease Risk in People Living with HIV: A Multicentre Non-Randomized Controlled Trial · Infectious Diseases and Therapy · 2026 · Same journal
• HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort · Infectious Diseases and Therapy · 2026 · Same journal
• Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis · Infectious Diseases and Therapy · 2026 · Same journal
• Hospitalisation Burden of Human Metapneumovirus and Respiratory Syncytial Virus in Adults by Age and Comorbidity Status in Scotland: A Retrospective Analysis · Infectious Diseases and Therapy · 2026 · Same journal
• Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection · Infectious Diseases and Therapy · 2026 · Same journal
• Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019–2025: Analysis of Nationwide Hospital Data · Infectious Diseases and Therapy · 2026 · Same journal